NL-OMON24824尚未招募不适用
A randomised controlled trial of oral S-ketamine as add-on medication for patients with treatment-resistant major depressive disorder
MCG0 个研究点目标入组 128 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 128
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male or female, age range: 18 to 80 years;
- •- Signed informed consent;
排除标准
- •- Bipolar depression or depression with psychotic features, according to the DSM-5;
- •- Previous or comorbid schizophrenia spectrum or other psychotic disorder according to the DSM-5, not including MDD with psychotic features;
研究者
相似试验
已完成
3 期
A randomised controlled trial of oral S-ketamine as add-on medication for patients with treatment-resistant major depressive disordersadness10027946DepressionNL-OMON46103niversitair Medisch Centrum Groningen113
进行中（未招募）
1 期
Oral ketamine for treating depressioEUCTR2015-003957-16-NLniversity Medical Centre Groningen
招募中
2 期
Oral Ketamine Trial on people aged 16 years and older with Treatment-Resistant DepressioMental Health - DepressionTreatment-Resistant DepressionACTRN12621000429853Thompson Institute, University of the Sunshine Coast25
已完成
2 期
Oral Ketamine Trial on SuicidalityACTRN12618001412224Sunshine Coast Mind and Neuroscience - Thompson Institute, University of the Sunshine Coast40
尚未招募
4 期
Therapeutic efficacy of oral ketamine in obsessive compulsive disorderCTRI/2021/09/036469GMC RH Patiala